Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
fda
life sciences
national blog main
alexion pharmaceuticals
alirocumab
alnylam pharmaceuticals
amgen
amyotrophic lateral sclerosis (als)
atea pharmaceuticals
autoimmune disorders
boston
complement system
coronavirus
covid-19
evolocumab
generalized myasthenia gravis
immune-mediated necrotizing myopathy
inclisiran
national top stories
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
ra pharmaceuticals
rare disease drugs
regeneron pharmaceuticals
rna interference
roche
sanofi
the medicines company
ucb
zilucoplan
What
deal
3
×
drug
3
×
medicines
new
pharmaceuticals
acquire
agreed
alternative
announced
antiviral
atea
autoimmune
billion
brings
candidate
cash
cholesterol
company
compound
coronavirus
cure
currently
developme
disease
expensive
far
fda
giant
groundbreaking
lead
medco
medicine
novartis
novel
oral
pharma
poised
potential
ra
ready
Language
unset
3
×
Current search:
deal
×
drug
×
unset
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma